Innocan Pharma Announces Mackie Research’s Institutional Sales Group Issues Enterprise Publication on the Company

Innocan Pharma Corporation (CNSX: INNO) (FSE: IP4) (the “Company” or “Innocan“), is pleased to announce that Mackie Research Capital Corporation’s institutional sales group has issued …